All updated as on -
From 2024–2031, the worldwide cell separation industry is projected to increase from an initial 2023 valuation of $8.39B at a CAGR (compound annual growth rate) of 11.82%.
Designing and developing biologics, producing therapeutic proteins, conducting in-vitro diagnostics, and many more research applications all rely on cell separation. The government's ongoing efforts to enhance the biotechnology industry and the increasing number of cases of chronic and infectious diseases including COVID-19 and cancer are driving forces behind the market's expansion. A major factor in the market's expansion is new product development.
The term "cell separation" refers to the steps used to isolate specific cell populations from larger ones in a biological sample. Cell populations are isolated using several technologies. In order to identify and remove specific cell types, these technologies use characteristics specific to particular cells, such as their size, density, electric charge, shape, or protein expression. These methods encompass density gradient centrifugation, magnetic-activated cell sorting, and fluorescence-activated cell sorting (FACS).
There are many research applications for cell separation, including biologics design and development, therapeutic protein production, in-vitro diagnostics, and capturing circulating tumor cells in the blood, isolating immune cells from peripheral blood, preparing a blood sample separated from plasma, separating bacteria from food, studying the effects of drug candidates on cell types, isolating white blood cells from tissue, and recovering mononucleated cells from the blood.
Companies like Bionano Genomics, NanoString Technologies, and Levitas Bio have expanded their offerings and implemented product development methods. As an example, the next-gen platform for cell separation, the LeviCell EOS System, was introduced by Levitas Bio in April 2023. The new solution outperforms the company's previous offerings in terms of throughput and allows for the selective isolation of live cells. Furthermore, scientists have a chance to study and understand this new infectious virus thanks to the COVID-19 pandemic, which could lead to the development of treatments and diagnostic tools.
The global spread of the COVID-19 epidemic disrupted supply chains in nearly every industry. Nevertheless, scientists now have a golden chance thanks to the COVID-19 pandemic to learn everything they can about this novel infectious virus in the hopes of creating diagnostic and therapy tools. New vaccines, treatments, and testing kits utilizing stem cells or regenerative medicine are the result of quick and substantial research and development efforts by a number of pharmaceutical and biotech behemoths. The demand for technologies that separate cells in research has been greatly increased as a result of this. The California Institute for Regenerative Medicine (CIRM) has allocated USD 5 million to support stem cell and regenerative medicine studies that have been peer-reviewed in the hopes of finding a therapy for COVID-19 as soon as possible. Rapid response research utilizing a stem cell or regenerative medicine strategy to treat COVID-19 is being supported by Stem Cell Network (SCN), which is offering up to USD 500,000 in funding.
The rising prevalence of cancer and infectious disorders like COVID-19 is driving this market's expansion. The market is expected to be driven by technology developments, a growing emphasis on customized treatment, and increased government support for cell-based research. The cell isolation market is seeing rapid expansion due to a number of causes, the most important of which are rising spending on cell biology research and the increasing number of market participants in emerging nations.
The pharmaceutical and biotechnology sectors are investing more and more in research and development, which should lead to the widespread use of cutting-edge tools and techniques, which in turn should boost sales. Yet, there is a vast array of expenses associated with cell separation methods, including equipment, chemicals, kits, sera, and services. Both the reagents and the equipment needed to separate cells are somewhat pricey, depending on their intended usage. During the projected period, these factors are expected to impede the market's growth.
Report Coverage
Global Cell Separation research report categorizes the market for global based on various segments and regions, forecasts revenue growth, and analyzes trends in each submarket. Global Cell Separation report analyses the key growth drivers, opportunities, and challenges influencing the global market. Recent market developments and Cell Separation competitive strategies such as expansion, product launch and development, partnership, merger, and acquisition have been included to draw the competitive landscape in the market. The report strategically identifies and profiles the key Cell Separation market players and analyses their core competencies in each global market sub-segments.
Key Points Covered in the Report
Competitive Environment:
The research provides an accurate study of the major organisations and companies operating in the global Cell Separation market, along with a comparative evaluation based on their product portfolios, corporate summaries, geographic reach, business plans, Cell Separation market shares in specific segments, and SWOT analyses. A detailed analysis of the firms' recent news and developments, such as product development, inventions, joint ventures, partnerships, mergers and acquisitions, strategic alliances, and other activities, is also included in the study. This makes it possible to assess the level of market competition as a whole.
List of Major Market Participants
MiltenyiBiotec, Merck KgaA, PluriSelect Life Science UG & Co. KG, Becton Dickinson and Company, STEMCELL Technologies Inc., GE Healthcare, Beckman Coulter, Inc., Terumo BCT, Thermo Fisher Scientific, Bio-Rad Laboratories Inc, BD, Danaher, GenScript, Miltenyi Biotec, Corning Inc.
Primary Target Market
Market Segment:
This study forecasts global, regional, and country revenue from 2019 to 2031. INFINITIVE DATA EXPERT has segmented the global Cell Separation market based on the below-mentioned segments:
Global Cell Separation Market, By Technique
Centrifugation
Surface Marker
Filtration
Global Cell Separation market, By Application
Research Laboratories and Institutes
Biotechnology and Biopharmaceutical Companies
Others
Global Cell Separation Market, By End User
Hospitals
Ambulatory Surgical Centers
Others
Global Cell Separation market, Regional Analysis
Designing and developing biologics, producing therapeutic proteins, conducting in-vitro diagnostics, and many more research applications all rely on cell separation. The government's ongoing efforts to enhance the biotechnology industry and the increasing number of cases of chronic and infectious diseases including COVID-19 and cancer are driving forces behind the market's expansion. A major factor in the market's expansion is new product development.
The term "cell separation" refers to the steps used to isolate specific cell populations from larger ones in a biological sample. Cell populations are isolated using several technologies. In order to identify and remove specific cell types, these technologies use characteristics specific to particular cells, such as their size, density, electric charge, shape, or protein expression. These methods encompass density gradient centrifugation, magnetic-activated cell sorting, and fluorescence-activated cell sorting (FACS).
There are many research applications for cell separation, including biologics design and development, therapeutic protein production, in-vitro diagnostics, and capturing circulating tumor cells in the blood, isolating immune cells from peripheral blood, preparing a blood sample separated from plasma, separating bacteria from food, studying the effects of drug candidates on cell types, isolating white blood cells from tissue, and recovering mononucleated cells from the blood.
Companies like Bionano Genomics, NanoString Technologies, and Levitas Bio have expanded their offerings and implemented product development methods. As an example, the next-gen platform for cell separation, the LeviCell EOS System, was introduced by Levitas Bio in April 2023. The new solution outperforms the company's previous offerings in terms of throughput and allows for the selective isolation of live cells. Furthermore, scientists have a chance to study and understand this new infectious virus thanks to the COVID-19 pandemic, which could lead to the development of treatments and diagnostic tools.
The global spread of the COVID-19 epidemic disrupted supply chains in nearly every industry. Nevertheless, scientists now have a golden chance thanks to the COVID-19 pandemic to learn everything they can about this novel infectious virus in the hopes of creating diagnostic and therapy tools. New vaccines, treatments, and testing kits utilizing stem cells or regenerative medicine are the result of quick and substantial research and development efforts by a number of pharmaceutical and biotech behemoths. The demand for technologies that separate cells in research has been greatly increased as a result of this. The California Institute for Regenerative Medicine (CIRM) has allocated USD 5 million to support stem cell and regenerative medicine studies that have been peer-reviewed in the hopes of finding a therapy for COVID-19 as soon as possible. Rapid response research utilizing a stem cell or regenerative medicine strategy to treat COVID-19 is being supported by Stem Cell Network (SCN), which is offering up to USD 500,000 in funding.
The rising prevalence of cancer and infectious disorders like COVID-19 is driving this market's expansion. The market is expected to be driven by technology developments, a growing emphasis on customized treatment, and increased government support for cell-based research. The cell isolation market is seeing rapid expansion due to a number of causes, the most important of which are rising spending on cell biology research and the increasing number of market participants in emerging nations.
The pharmaceutical and biotechnology sectors are investing more and more in research and development, which should lead to the widespread use of cutting-edge tools and techniques, which in turn should boost sales. Yet, there is a vast array of expenses associated with cell separation methods, including equipment, chemicals, kits, sera, and services. Both the reagents and the equipment needed to separate cells are somewhat pricey, depending on their intended usage. During the projected period, these factors are expected to impede the market's growth.
Report Coverage
Global Cell Separation research report categorizes the market for global based on various segments and regions, forecasts revenue growth, and analyzes trends in each submarket. Global Cell Separation report analyses the key growth drivers, opportunities, and challenges influencing the global market. Recent market developments and Cell Separation competitive strategies such as expansion, product launch and development, partnership, merger, and acquisition have been included to draw the competitive landscape in the market. The report strategically identifies and profiles the key Cell Separation market players and analyses their core competencies in each global market sub-segments.
| REPORT ATTRIBUTES | DETAILS |
|---|---|
| Study Period | 2017-2031 |
| Base Year | 2023 |
| Forecast Period | 2023-2031 |
| Historical Period | 2017-2021 |
| Unit | Value (USD Billion) |
| Key Companies Profiled | MiltenyiBiotec, Merck KgaA, PluriSelect Life Science UG & Co. KG, Becton Dickinson and Company, STEMCELL Technologies Inc., GE Healthcare, Beckman Coulter, Inc., Terumo BCT, Thermo Fisher Scientific, Bio-Rad Laboratories Inc, BD, Danaher, GenScript, Miltenyi Biotec, Corning Inc. |
| Segments Covered | • By Product |
| Customization Scope | Free report customization (equivalent to up to 3 analyst working days) with purchase. Addition or alteration to country, regional & segment scope |
Key Points Covered in the Report
- Market Revenue of Cell Separation Market from 2021 to 2031.
- Market Forecast for Cell Separation Market from 2021 to 2031.
- Regional Market Share and Revenue from 2021 to 2031.
- Country Market share within region from 2021 to 2031.
- Key Type and Application Revenue and forecast.
- Company Market Share Analysis, Cell Separation competitive scenario, ranking, and detailed company
profiles. - Market driver, restraints, and detailed COVID-19 impact on Cell Separation
Market
Competitive Environment:
The research provides an accurate study of the major organisations and companies operating in the global Cell Separation market, along with a comparative evaluation based on their product portfolios, corporate summaries, geographic reach, business plans, Cell Separation market shares in specific segments, and SWOT analyses. A detailed analysis of the firms' recent news and developments, such as product development, inventions, joint ventures, partnerships, mergers and acquisitions, strategic alliances, and other activities, is also included in the study. This makes it possible to assess the level of market competition as a whole.
List of Major Market Participants
MiltenyiBiotec, Merck KgaA, PluriSelect Life Science UG & Co. KG, Becton Dickinson and Company, STEMCELL Technologies Inc., GE Healthcare, Beckman Coulter, Inc., Terumo BCT, Thermo Fisher Scientific, Bio-Rad Laboratories Inc, BD, Danaher, GenScript, Miltenyi Biotec, Corning Inc.
Primary Target Market
- Market Players of Cell Separation
- Investors
- End-users
- Government Authorities
- Consulting And Research Firm
- Venture capitalists
- Third-party knowledge providers
- Value-Added Resellers (VARs)
Market Segment:
This study forecasts global, regional, and country revenue from 2019 to 2031. INFINITIVE DATA EXPERT has segmented the global Cell Separation market based on the below-mentioned segments:
Global Cell Separation Market, By Technique
Centrifugation
Surface Marker
Filtration
Global Cell Separation market, By Application
Research Laboratories and Institutes
Biotechnology and Biopharmaceutical Companies
Others
Global Cell Separation Market, By End User
Hospitals
Ambulatory Surgical Centers
Others
Global Cell Separation market, Regional Analysis
- Europe: Germany, Uk, France, Italy, Spain, Russia, Rest of Europe
- The Asia Pacific: China,Japan,India,South Korea,Australia,Rest of Asia Pacific
- South America: Brazil, Argentina, Rest of South America
- Middle East & Africa: UAE, Saudi Arabia, Qatar, South Africa, Rest of Middle East & Africa
About This Research
You will get in-depth and extensive cell separation market market research and competitor analysis for your business to help you develop more profound insights into the cell separation market Market.
Through INFINITIVE Data Expert is a professional Market Research services, I will identify the cell separation market market size, demand & opportunities, growth rate, and target audience with a comprehensive analysis of your competitors.